Month: March 2020

Health By Helen Branswell

As coronavirus spreads, doctors in the ER warn ‘the worst of it has not hit us yet’

Health By Matthew Herper

Test makers are moving fast, but the coronavirus may be moving faster

Health By Sharon Begley

What explains Covid-19’s lethality for the elderly? Scientists look to ‘twilight’ of the immune system

Biotech By Adam Feuerstein

Amarin loses legal fight over heart drug patent; shares sink

First Opinion By Andrew Meshnick, Brian J. Miller, and Boris Lushniak

It’s past time to fully deploy the U.S. Public Health Service Commissioned Corps to fight Covid-19

Health By Adam Feuerstein

Biotech VC Bob Nelsen called it right on the coronavirus. Now he has thoughts on therapeutics — and masks

Pharmalot By Ed Silverman

Pharmalittle: Drug pricing legislation is on the back burner; FDA issues emergency use for old malaria drugs

In the Lab By Matthew Herper

CRISPR pioneer Doudna opens lab to run Covid-19 tests

The Readout By Meghana Keshavan

Pricing talks halt, candor from Gilead, & a unique Alzheimer’s trial

Morning Rounds By Shraddha Chakradhar

White House extends social distancing timeline & extreme heat and cardiovascular deaths

Biotech By Damian Garde, Rebecca Robbins, and Adam Feuerstein

AC Immune bets that its Alzheimer’s trial design could provide a cleaner test of the amyloid hypothesis

Politics By Lev Facher

Lawmakers’ coronavirus response means delays for drug pricing legislation

Video By Alex Hogan

Watch: Ventilators are in high demand for Covid-19 patients. How do they work?

Health Tech By Casey Ross and Rebecca Robbins

Debate flares over using AI to detect Covid-19 in lung scans

Health By Helen Branswell

Two new road maps lay out possible paths to end coronavirus lockdowns

First Opinion By Jason Karlawish

Hospitalized adults need their caregivers — they aren’t visitors